Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -136.83% is 107% below its 5-year average of -66.08%, around the middle of its 5-year range (-225.64%–13.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.73% below its 12-month average of -96.54%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -136.83%.
RETURN ON EQUITY (ROE)
-136.83%
RETURN ON EQUITY (ROE) AVG TTM
-96.54%
RETURN ON EQUITY (ROE) AVG 3Y
-83.56%
RETURN ON EQUITY (ROE) AVG 5Y
-66.08%
RETURN ON EQUITY (ROE) AVG 10Y
-78.28%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-41.73%
CURRENT VS 3Y AVG
-63.76%
CURRENT VS 5Y AVG
-107.06%
CURRENT VS 10Y AVG
-74.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
-280.03%
vs the sector median at left
Eledon Pharmaceuticals, Inc.
Market Cap
$192.97M
Return on Equity (ROE)
-136.83%
TTM Avg
-96.54%
3Y Avg
-83.56%
5Y Avg
-66.08%
Market Cap
$184.12M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$202.05M
Return on Equity (ROE)
-47.78%
TTM Avg
-64.50%
3Y Avg
-55.96%
5Y Avg
-125.52%
Market Cap
$179.70M
Return on Equity (ROE)
-21.57%
TTM Avg
-470.91%
3Y Avg
-299.18%
5Y Avg
-180.76%
Market Cap
$206.61M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$176.96M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$174.17M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$173.04M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$172.99M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $192.97M | -136.83% | -96.54% | -83.56% | -66.08% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -19.01% | -54.50% | -75.60% | -59.28% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | -47.78% | -64.50% | -55.96% | -125.52% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | -21.57% | -470.91% | -299.18% | -180.76% |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -116.42% | -18.43% | -136.68% | -137.61% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -215.26% | -150.35% | 8.65% | -35.35% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | -44.23% | -36.61% | -30.86% | -42.66% |
| Compugen Ltd. (CGEN)vs › | $218.42M | 39.66% | 4.24% | -15.88% | -20.06% |
ROE
-136.8%
ROA
-78.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -136.83% |
| 2026-03-31 | -77.79% |
| 2025-12-31 | -56.26% |
| 2025-09-30 | -225.64% |
| 2025-06-30 | 13.81% |
| 2025-03-31 | -16.62% |
| 2024-12-31 | -30.63% |
| 2024-09-30 | -1.57% |
| 2023-09-30 | -158.56% |
| 2023-06-30 | -145.46% |
| 2023-03-31 | -118.83% |
| 2022-12-31 | -104.49% |
| 2022-09-30 | -27.21% |
| 2022-06-30 | -25.26% |
| 2022-03-31 | -22.95% |
| 2021-12-31 | -21.04% |
| 2021-09-30 | -18.51% |
| 2021-06-30 | -15.65% |
| 2021-03-31 | -12.58% |
| 2020-12-31 | -11.97% |
| 2020-09-30 | -97.88% |
| 2020-06-30 | -190.25% |
| 2020-03-31 | -164.38% |
| 2019-12-31 | -169.16% |
| 2019-09-30 | -123.01% |
| 2019-06-30 | -106.31% |
| 2019-03-31 | -162.55% |
| 2018-12-31 | -97.05% |
| 2018-09-30 | -63.31% |
| 2018-06-30 | -51.48% |
| 2018-03-31 | -59.87% |
| 2017-12-31 | -67.43% |
| 2017-09-30 | -71.50% |
| 2017-06-30 | -58.91% |
| 2017-03-31 | -34.87% |
| 2016-12-31 | -67.76% |
| 2016-09-30 | -84.21% |
| 2016-06-30 | -90.78% |
| 2016-03-31 | -84.14% |
| 2015-12-31 | -73.05% |
| 2015-09-30 | -56.02% |
| 2015-06-30 | -42.07% |
| 2015-03-31 | -34.88% |
| 2014-12-31 | -22.51% |
| 2014-09-30 | -22.25% |
| 2014-06-30 | -99.27% |
